Clinical Trial Update: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [NA]

View source ↗

Summary

A completed clinical trial evaluated adding aprepitant to granisetron and dexamethasone to prevent nausea and vomiting in patients receiving cyclophosphamide be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gestational Trophoblastic Tumor
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Neuroblastoma
• Ovarian Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Aprepitant (aprepitant)
• DEXAMETHASONE (Dexamethasone)
• Granisetron (granisetron)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer, Chronic Myeloproliferative Disorders | NA | Status: COMPLETED | Results posted: 2014-10-03